Alivus Life Sciences Limited (NSE:ALIVUS)
India
· Delayed Price · Currency is INR 919.75
+4.70 (0.51%)
Mar 9, 2026, 3:30 PM IST
Alivus Life Sciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2018 |
| Market Capitalization | 112,887 | 132,481 | 95,161 | 48,141 | 56,215 | - | Upgrade
|
| Market Cap Growth | -10.21% | 39.22% | 97.67% | -14.36% | - | - | Upgrade
|
| Enterprise Value | 106,963 | 128,178 | 90,913 | 44,570 | 52,405 | - | Upgrade
|
| Last Close Price | 919.75 | 1075.43 | 772.54 | 377.65 | 408.52 | - | Upgrade
|
| PE Ratio | 20.79 | 27.28 | 20.21 | 10.31 | 13.43 | - | Upgrade
|
| Forward PE | 18.97 | 23.14 | 16.54 | 9.96 | 11.60 | - | Upgrade
|
| PS Ratio | 4.49 | 5.55 | 4.17 | 2.23 | 2.65 | - | Upgrade
|
| PB Ratio | 3.74 | 4.70 | 4.08 | 2.25 | 2.74 | - | Upgrade
|
| P/TBV Ratio | 3.77 | 4.74 | 4.11 | 2.27 | 2.75 | - | Upgrade
|
| P/FCF Ratio | - | 58.79 | 33.44 | 33.62 | 12.08 | - | Upgrade
|
| P/OCF Ratio | - | 33.84 | 23.01 | 15.73 | 9.41 | - | Upgrade
|
| PEG Ratio | 1.72 | 1.45 | 1.12 | 0.98 | 0.72 | - | Upgrade
|
| EV/Sales Ratio | 4.26 | 5.37 | 3.98 | 2.06 | 2.47 | - | Upgrade
|
| EV/EBITDA Ratio | 13.78 | 18.88 | 13.59 | 6.97 | 8.53 | - | Upgrade
|
| EV/EBIT Ratio | 15.03 | 20.55 | 14.61 | 7.42 | 9.05 | - | Upgrade
|
| EV/FCF Ratio | - | 56.88 | 31.95 | 31.12 | 11.26 | - | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.02 | 0.01 | 0.01 | 0.00 | 1.24 | Upgrade
|
| Debt / EBITDA Ratio | 0.08 | 0.08 | 0.03 | 0.03 | 0.00 | 1.57 | Upgrade
|
| Debt / FCF Ratio | - | 0.25 | 0.06 | 0.14 | 0.01 | 2.91 | Upgrade
|
| Net Debt / Equity Ratio | -0.20 | -0.17 | -0.12 | -0.12 | -0.25 | 1.08 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.77 | -0.72 | -0.42 | -0.41 | -0.83 | 1.37 | Upgrade
|
| Net Debt / FCF Ratio | - | -2.18 | -1.00 | -1.85 | -1.09 | 2.54 | Upgrade
|
| Asset Turnover | - | 0.76 | 0.82 | 0.84 | 0.95 | 1.01 | Upgrade
|
| Inventory Turnover | - | 1.69 | 1.64 | 1.87 | 2.07 | 2.02 | Upgrade
|
| Quick Ratio | - | 3.31 | 2.64 | 2.34 | 3.10 | 0.66 | Upgrade
|
| Current Ratio | - | 4.97 | 4.37 | 3.73 | 4.60 | 1.15 | Upgrade
|
| Return on Equity (ROE) | - | 18.86% | 21.07% | 22.28% | 29.83% | 60.91% | Upgrade
|
| Return on Assets (ROA) | - | 12.45% | 14.01% | 14.52% | 16.20% | 18.86% | Upgrade
|
| Return on Invested Capital (ROIC) | 21.98% | 21.18% | 23.67% | 26.11% | 27.58% | 27.79% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 21.20% | 25.80% | 27.20% | 27.70% | 72.40% | Upgrade
|
| Earnings Yield | 4.82% | 3.67% | 4.95% | 9.70% | 7.45% | - | Upgrade
|
| FCF Yield | - | 1.70% | 2.99% | 2.97% | 8.28% | - | Upgrade
|
| Dividend Yield | 0.55% | 0.46% | 2.91% | 5.56% | 5.14% | - | Upgrade
|
| Payout Ratio | - | - | 58.55% | 82.64% | 30.73% | - | Upgrade
|
| Buyback Yield / Dilution | -0.01% | -0.17% | -0.13% | -4.25% | -9.03% | - | Upgrade
|
| Total Shareholder Return | 0.53% | 0.30% | 2.79% | 1.31% | -3.89% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.